SCHEMBL1134849

SCHEMBL1134849

Cn1cc(C(=O)Nc2ccc(F)cc2-c2ccc(Cl)cc2)c(C(F)F)n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 8/20 0.49
CSNK1D P48730 3/20 0.44
CSNK1E P49674 3/20 0.44
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
TAS1R2 Q8TE23 1/20 0.43
THRB P10828 1/20 0.42
ANO1 Q5XXA6 3/20 0.42
ANO2 Q9NQ90 1/20 0.41
KDR P35968 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1136276 0.91 CHRM3 (0.51) CHRM3CHRM2CHRM1
SCHEMBL1767591 0.90 CHRM3 (0.46) CHRM3CHRM2CHRM1
SCHEMBL68043 0.90 CHRM3 (0.51) CHRM3LMNACHRM2CHRM1THRB
SCHEMBL29445383 0.90 CHRM3 (0.51) CHRM3LMNACHRM2CHRM1THRB
SCHEMBL29349968 0.90 CHRM3 (0.51) CHRM3LMNACHRM2CHRM1THRB
SCHEMBL29445388 0.90 CHRM3 (0.49) CHRM3CSNK1DCSNK1ELMNATAS1R3
SCHEMBL675989 0.90 CHRM3 (0.49) CHRM3CSNK1DCSNK1ELMNATAS1R3
SCHEMBL13491718 0.89 CHRM3 (0.50) CHRM3LMNACHRM2CHRM1
SCHEMBL1134824 0.89 CHRM3 (0.51) CHRM3CHRM2CHRM1TAS1R3TAS1R1
SCHEMBL303047 0.89 CHRM3 (0.51) CHRM3CSNK1DCSNK1ECHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285779-B1 Method for manufacturing aryl carboxamides BASF SE (DE) 2013-03-27 EP claimed
US-8350046-B2 Method for manufacturing aryl carboxamides BASF SE (DE) 2013-01-08 US claimed
US-20110054183-A1 Method For Manufacturing Aryl Carboxamides BASF SE 2011-03-03 US claimed
EP-2300417-B1 PROCESS FOR PREPARING 2-(AMINOMETHYLIDENE)-4,4-DIFLUORO-3-OXOBUTYRIC ESTERS BASF SE (DE) 2015-07-22 EP disclosed
EP-2496560-B1 PROCESS FOR PREPARING 1,3-DISUBSTITUTED PYRAZOLE COMPOUNDS BASF SE (DE) 2015-04-22 EP disclosed
EP-2288597-B1 METHOD FOR PREPARING 1,3,4-SUBSTITUTED PYRAZOL COMPOUNDS BASF SE (DE) 2014-10-29 EP disclosed
EP-2496561-B1 PROCESS FOR PREPARING AMINALE AND THEIR USE FOR PREPARING 1,3-DISUBSTITUTED PYRAZOLE COMPOUNDS BASF SE (DE) 2014-06-04 EP disclosed
US-8598222-B2 Method for preparing 1,3,4-substituted pyrazol compounds BASF SE (DE) 2013-12-03 US disclosed
US-8592578-B2 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters BASF SE (DE) 2013-11-26 US disclosed
US-8586750-B2 Method for the production of halogen-substituted 2-(aminomethylidene)-3-oxobutyric acid esters BASF SE (DE) 2013-11-19 US disclosed
EP-2285779-B1 Method for manufacturing aryl carboxamides BASF SE (DE) 2013-03-27 EP disclosed
EP-2158185-A2 METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED PYRAZOLE COMPOUNDS Basf Se (DE) 2010-03-03 EP disclosed
WO-2009135808-A2 METHOD FOR PREPARING 1,3,4-SUBSTITUTED PYRAZOL COMPOUNDS BASF SE (DE) 2009-11-12 WO disclosed
WO-2009135860-A1 METHOD FOR MANUFACTURING ARYL CARBOXAMIDES BASF SE (DE) 2009-11-12 WO disclosed
WO-2009133178-A1 PROCESS FOR PREPARING 2-(AMINOMETHYLIDENE)-4,4-DIFLUORO-3-OXOBUTYRIC ESTERS BASF SE (DE) 2009-11-05 WO disclosed
WO-2009133179-A2 METHOD FOR THE PRODUCTION OF HALOGEN-SUBSTITUTED 2-(AMINOMETHYLIDENE)-3- OXOBUTYRIC ACID ESTERS BASF SE (DE) 2009-11-05 WO disclosed
EP-2049496-A2 3-DIFLUOROMETHYLPYRAZOLYLCARBOXANILIDES Bayer CropScience AG (DE) 2009-04-22 EP disclosed
WO-2008152138-A2 METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED PYRAZOLE COMPOUNDS BASF SE (DE) 2008-12-18 WO disclosed
WO-2008014905-A2 3-DIFLUOROMETHYLPYRAZOLYLCARBOXANILIDES BAYER CROPSCIENCE AG (DE) 2008-02-07 WO disclosed
WO-2008014905-A2 3-DIFLUOROMETHYLPYRAZOLYLCARBOXANILIDES BAYER CROPSCIENCE AG (DE) 2008-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054183-A1 Method For Manufacturing Aryl Carboxamides H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, CBR1 CHRM3 910/4885CSNK1D 249/4885CSNK1E 573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.